Introduction
Yeasts of the genus Candida are colonizers of human skin and mucous membranes that have been recognized as opportunistic pathogens among immunocompromised patients. Candidiasis has become a major problem in healthcare settings as it is generally diffi cult to diagnose and treat [1, 2] . The higher incidence of candidiasis amongst hospitalized patients in recent years has been attributed to advances in surgery, cancer treatment, critical care, the increase usage of broad-spectrum antimicrobials and HIV infections [2] . The association of candidiasis with catheter-related infections has been linked to the ability of the yeasts to form biofi lms on intravascular devices [2, 3] . It has been reported The proteinase agar clearance assay was performed according to . Briefl y, a chemically defi ned medium (20 ml) containing 1.5 % agar, 13 mM glycine, 29.4 mM KH 2 PO 4, 10 mM MgSO 4 and 3 μ M thiamine was prepared as the basal layer in a Petri dish. Five milliliters of this medium to which 1.0% (w/v) bovine serum albumin and 1.0% (w/v) galactose was added was then poured over the basal layer and allowed to set overnight. A loopful of an overnight yeast culture was then aseptically inoculated onto the agar. After 6 days of incubation at 30 ° C, residual protein in the agar was fi xed by fl ooding the agar with 10% (w/v) tannic acid for 5 min. The diameters of the colonies (a) and the diameters of the clearing zone around the colonies (b) were measured.
To assess the phospholipase activity, the egg-yolk agar plate method described by Price et al . [11] was used. Briefl y, egg yolk agar was prepared by incorporating a 50% (v/v) egg yolk suspension into Sabouraud ' s dextrose agar medium, along with 1 M sodium chloride and 5 mM calcium chloride. A loopful of an overnight yeast culture was aseptically inoculated onto the medium and after 6 days of incubation at 30 ° C, the diameters of the colonies (a) and the diameters of the precipitation zone around the colonies (b) were measured.
The production of the proteinase and phospholipase of the yeasts was designated as Pz ϭ a/b, as described by Price et al. [11] . Comparisons of the enzyme activity of Candida isolates were performed using the Mann-Whitney test of the statistical SPSS package (ver. 13.0). A P -value of Ͻ 0.05 was considered statistically signifi cant.
Determination of the in vitro biofi lm formation of Candida isolates
The in vitro biofi lm formation of Candida isolates was determined as described by Jin et al . [12] . Briefl y, an overnight yeast culture was suspended in RPMI 1640 broth medium supplemented with L-glutamine (Sigma, USA) to a fi nal concentration of 10 7 cells/ml (OD 530nm ϭ 0.38). One hundred microliters of the yeast suspension was then transferred to each well of a fl at-bottomed, 96-well polystyrene microtiter plate (Nunclon, USA). After incubation under shaking at 75 rpm at 37 ° C for 1.5 h, unattached cells were removed by washing twice with 150 μ l phosphate-buffered saline (PBS). Fresh RPMI 1640 medium (100 μ l) was then added to the microtiter wells to allow proliferation of the biofi lm. The metabolic activity of the biofi lm was measured by the XTT reduction assay after 48 h of incubation. The biofi lm in each well was washed twice with 200 μ l PBS before adding a solution containing 2, 3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2 H -tetrazolium hydroxide (XTT) with menadione. The absorbance of the resultant solution (100 μ l) after incubation for 1 h in the dark was measured with a spectrophotometer at 490 nm. Examination of biofi lm morphology was carried out with an inverted light microscope (Olympus, USA) at 200 ϫ magnifi cation. The experiments were performed in triplicate for each isolate.
Determination of planktonic and biofi lm MICs
The in vitro minimum inhibition concentration (MIC) of planktonic cells of each isolate to amphotericin and fl uconazole was determined using the microbroth dilution method as described in the CLSI M27-A2 document [13] . Final drug concentrations ranging from 0.0625 to 2 μ g/ml were prepared for amphotericin B, whereas for fl uconazole, drug concentrations of 0.125 -64 μ g/ml were used. The MIC for each isolate was determined after incubation at 37 ° C for 48 h. The MIC of amphotericin B was defi ned as the lowest concentrations at which there was an absence of growth. The MIC of fl uconazole was defi ned as the lowest drug concentration which achieved 80% growth inhibition as compared to the growth of the drug-free control. The biofi lm MIC for each yeast isolate was determined as described by Melo et al . [14] . Final drug concentrations ranging from 0.015 -8 μ g/ml were prepared for amphotericin B, whereas for fl uconazole, drug concentrations of 0.25 -128 μ g/ml were used. The biofi lm MIC of each isolate was determined on the basis of a 50% reduction in metabolic activity compared with the metabolic activity of the biofi lm in microtiter wells without the drug. The experiments were performed in duplicate for each isolate.
Results

Proteinase and phospholipase activities of Candida isolates
A total of 14 (93.7%) of the 15 C. albicans isolates and 23 (88.5%) of the 26 non-C. albicans Candida isolates There was an increase (more than 32 folds) in the biofi lm amphotericin MICs for all Candida isolates as compared to the planktonic cells, except for C. glabrata (Table 2) . C. glabrata demonstrated similar MIC 50 (0.25 μ g/ml) against amphotericin for both biofi lm and planktonic cells. Decreased antifungal activity of fl uconazole against Candida biofi lms was refl ected by the higher MIC 50 ( Ն 128 μ g/ml) of all the isolates investigated in the current study.
Discussion
Proteinase and phospholipase are hydrolytic enzymes that have been identifi ed as playing essential roles in the pathogenicity of C. albicans [7 -9] . The production of these enzymes has also been demonstrated in non-C. albicans Candida species in this and other studies [7, 9, 15, 16] . There was no signifi cant difference in the proteinase activity between C. albicans and the non-C. albicans Candida isolates in the current study ( P ϭ 0.272), suggesting the importance of this enzyme to both groups of the yeasts. Collectively, the detection rates for proteinase activity of C. albicans isolates and non-C. albicans Candida isolates from blood cultures in this study were regarded high (93.7% and 88.5% respectively) as compared to a previous study (56.7% and 43.9%, reported by Oksuz et al . [15] ), whereby isolates from anatomically distinct sites of healthy adults were used.
Our fi ndings concur with the results of previous studies, in which phospholipase activity was detected in higher percentages (53.8 -73%) in C. albicans isolates as compared to those of non-C. albicans Candida isolates (2 -17%) [15 -18] . The phospholipase activity of C. albicans was also signifi cantly higher as compared to the non-C. albicans Candida isolates in the current study ( P ϭ 0.003). Unlike phospholipase of C. albicans which has been implicated in the early steps of host invasion [7] , the low and undetectable phospholipase activity in the majority of the non-C. albicans Candida species suggests that the enzyme is probably not a signifi cant virulence factor for these species. exhibited proteinase activity (Table 1) . Phospholipase activity was detected in 11 (73.3%) of the C. albicans isolates but only two (7.7%) of the non-C. albicans Candida isolates, i.e., one isolate each of C. parapsilosis and C. rugosa . Table 1 shows the quantitation of biofi lm metabolic activity of Candida isolates using the XTT-reduction assays. A total of 14 yeast isolates, including six C. albicans , four C. parapsilosis and four C. tropicalis were considered as high biofi lm producers, as indicated by the high XTT OD readings ( Ն 0.200). Strain to strain variability was observed in the biofi lm metabolic activity among the isolates of the same species, as refl ected by the standard deviation in the OD readings of each species. Biofi lms of C. albicans , C. tropicalis and C. parapsilosis demonstrated a dense network of yeast cells with extensive fi lamentation after 48 h of incubation. The fi lamentation was not obvious for the C. rugosa , C. krusei and C. glabrata isolates.
Biofi lm formation of Candida isolates
Antifungal susceptibilities of biofi lm and planktonic cells
The results of the antifungal susceptibility testing of the biofi lm and planktonic cells of the yeast isolates are summarized in Table 2 . While none of the C. albicans isolates were resistant to amphotericin, two C. tropicalis isolates were considered as resistant to this antifungal (MIC Ն 2 μ g/ml). The concentrations of amphotericin necessary to inhibit 50% of the isolates (MIC 50 ) were 0.25 μ g/ml for both C. albicans and non-C. albicans Candida isolates. In vitro fl uconazole resistance ( Ն 64 μ g/ml) was detected in C. albicans (four isolates), C. tropicalis (one isolate), C. parapsilosis (three isolates), C. glabrata (one isolates), and C. krusei (one isolate), respectively. The concentration of fl uconazole necessary to inhibit 50% of the isolates (MIC 50 ) was 2 μ g/ml for both C. albicans and non-C. albicans Candida species. Note. The production of the proteinase and phospholipase of the yeasts was designated as Pz ϭ a/b, as described by Price et al . [11] .
Consistent with other studies, the fi ndings in the present investigation demonstrated the variable ability of Candida isolates to form biofi lms in vitro [19 -21] . There was no signifi cant difference in the biofi lm forming abilities between C. albicans and non-C. albicans Candida isolates ( P ϭ 0.379), although biofi lm production was more commonly observed for isolates of C. tropicalis , followed by C. albicans on the surface of catheter materials than noted in a previous study [21] . In addition, there was no obvious association of biofi lm production with proteinase and phospholipase activity of the isolates presently investigated, although recent fi ndings indicated that aspartyl proteinase production might be enhanced during the biofi lm formation phase of C. albicans [22] .
The decreased in vitro antifungal activities of amphotericin and fl uconazole against biofi lms of Candida isolates noted in the current study, is in agreement with previous studies that Candida biofi lms are more resistant to antifungal agents than their planktonic counterparts [19 -21] . According to Ramage et al . [23] , drug resistance in biofi lms is attributed to the high density of cells within the biofi lms, expression of resistance genes and the presence of the biofi lm matrix and ' persister ' cells. A recent study reported that although ' persister ' populations were present in biofi lms of C. albicans , C. krusei and C. parapsilosis after exposure to amphotericin, they were absent from those of C. glabrata [24] . This may be a possible explanation for the lower resistance of C. glabrata biofi lms against amphotericin in the current study, other than the low biofi lm formation ability of the isolates [21] .
In conclusion, the herein reported fi ndings demonstrate that proteinase and phospholipase are stable characteristics of C. albicans . While proteinase activity was detected in most non-C. albicans Candida isolates, the phospholipase activity of these isolates was considered as weak and insignifi cant. Several amphotericin and fl uconazole resistant Candida isolates were reported in the current study. However as the number of Candida isolates was small, we are not able to comment on the overall incidence of antifungal resistance of Candida isolates in Malaysia until more extensive work is carried out. Antifungal therapy by amphotericin and fl uconazole seems to be insuffi cient for treatment of Candida biofi lms as complete killing of biofi lm cells at the highest concentration (8 μ g/ml for amphotericin and 128 μ g/ml for fl uconazole) was not possible for the majority of the herein investigated isolates.
